Cargando…
Production of Recombinant Anti-Cancer Vaccines in Plants
Plant expression systems have been developed to produce anti-cancer vaccines. Plants have several advantages as bioreactors for the production of subunit vaccines: they are considered safe, and may be used to produce recombinant proteins at low production cost. However, several technical issues hind...
Autores principales: | Lee, Jeong Hwan, Ko, Kisung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499611/ https://www.ncbi.nlm.nih.gov/pubmed/28554196 http://dx.doi.org/10.4062/biomolther.2016.126 |
Ejemplares similares
-
Production of Monoclonal Antibodies in Plants for Cancer Immunotherapy
por: Moussavou, Ghislain, et al.
Publicado: (2015) -
Plant Recycling for Molecular Biofarming to Produce Recombinant Anti-Cancer mAb
por: Kim, Deuk-Su, et al.
Publicado: (2016) -
Optimization of Ammonium Sulfate Concentration for Purification of Colorectal Cancer Vaccine Candidate Recombinant Protein GA733-FcK Isolated from Plants
por: Park, Se-Ra, et al.
Publicado: (2015) -
N-Glycosylation Modification of Plant-Derived Virus-Like Particles: An Application in Vaccines
por: Kim, Hyun-Soon, et al.
Publicado: (2014) -
Endoplasmic reticulum retention motif fused to recombinant anti-cancer monoclonal antibody (mAb) CO17-1A affects mAb expression and plant stress response
por: Song, Ilchan, et al.
Publicado: (2018)